Research Topics
Species | Lars HolmbergSummaryAffiliation: Uppsala University Country: Sweden Publications
| Collaborators
|
Detail Information
Publications
Coffee, tea, and caffeine consumption and breast cancer incidence in a cohort of Swedish womenKarin B Michels
Obstetrics and Gynecology Epidemiology Center, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA
Ann Epidemiol 12:21-6. 2002..04 (95% CI 0.87-1.24) compared to women in the lowest quintile. CONCLUSIONS: In this large cohort of Swedish women, consumption of coffee, tea, and caffeine was not associated with breast cancer incidence...
Differences in management of older women influence breast cancer survival: results from a population-based database in SwedenSonja Eaker
Regional Oncologic Centre ROC, University Hospital, SE 751 85 Uppsala, Sweden
PLoS Med 3:e25. 2006..We sought to investigate whether differences in the management of older women with breast cancer are associated with survival...
Reducing cancer drug doses in obese patients: dogma disputedLars Holmberg
Regional Oncologic Centre, University Hospital, S-751 85 Uppsala, Sweden
Lancet 366:1056-7. 2005
[Insufficient studies of diagnostic cancer tests. Neither systematic review nor original studies come up to expectations]Lars Holmberg
Regionalt onkologiskt centrum, Akademiska sjukhuset, Uppsala
Lakartidningen 104:1308-9. 2007
Prognostic markers under watchful waiting and radical prostatectomyLars Holmberg
Regional Oncologic Center, University Hospital, Uppsala, Sweden
Hematol Oncol Clin North Am 20:845-55. 2006..Because overall prognostic information obtained by these parameters or by tumor stage was not provided in our publication, we now present these data in the two study arms separately...
Radical prostatectomy versus watchful waiting in localized prostate cancer: the Scandinavian prostate cancer group-4 randomized trialAnna Bill-Axelson
Department of Urology, University Hospital, Uppsala, Sweden
J Natl Cancer Inst 100:1144-54. 2008..In 2005, we reported that radical prostatectomy improved prostate cancer survival compared with watchful waiting after a median of 8.2 years of follow-up. We now report results after 3 more years of follow-up...
Radical prostatectomy versus watchful waiting in early prostate cancerAnna Bill-Axelson
Department of Urology, University Hospital, Uppsala, Sweden
N Engl J Med 364:1708-17. 2011..In 2008, we reported that radical prostatectomy, as compared with watchful waiting, reduces the rate of death from prostate cancer. After an additional 3 years of follow-up, we now report estimated 15-year results...
Long-term quality-of-life outcomes after radical prostatectomy or watchful waiting: the Scandinavian Prostate Cancer Group-4 randomised trialEva Johansson
Department of Surgical Sciences, University Hospital of Uppsala, Uppsala, Sweden
Lancet Oncol 12:891-9. 2011..We report results for quality of life for men in the Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) after a median follow-up of more than 12 years...
Radical prostatectomy versus watchful waiting in early prostate cancerAnna Bill-Axelson
Department of Urology, University Hospital, Uppsala, Sweden
N Engl J Med 352:1977-84. 2005..In 2002, we reported the initial results of a trial comparing radical prostatectomy with watchful waiting in the management of early prostate cancer. After three more years of follow-up, we report estimated 10-year results...
Social differences in breast cancer survival in relation to patient management within a National Health Care System (Sweden)Sonja Eaker
Department of Surgery, Uppsala University, Uppsala, Sweden
Int J Cancer 124:180-7. 2009....
Serum levels of selenium and smoking habits at age 50 influence long term prostate cancer risk; a 34 year ULSAM follow-upBirgitta Grundmark
Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
BMC Cancer 11:431. 2011..We investigated the relation between s-Se, smoking and non-screening detected PrCa and explored if polymorphisms in two DNA repair genes: OGG1 and MnSOD, influenced any effect of s-Se...
Borderline ovarian tumors in Sweden 1960-2005: trends in incidence and age at diagnosis compared to ovarian cancerIngiridur Skirnisdottir
Department of Women s and Children s Health, Obstetrics and Gynecology, Uppsala University, Uppsala, Sweden
Int J Cancer 123:1897-901. 2008....
Gene copy number aberrations are associated with survival in histologic subgroups of non-small cell lung cancerPatrick Micke
Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
J Thorac Oncol 6:1833-40. 2011..To maximize the chance to identify clinically relevant events, we applied a strategy involving two prognostically extreme patient groups...
Non-genital tract metastases to the ovaries presented as ovarian tumors in Sweden 1990-2003: occurrence, origin and survival compared to ovarian cancerIngiridur Skirnisdottir
Department of Women s and Children s Health, Obstetrics and Gynecology, Akademiska University Hospital, Uppsala, Sweden
Gynecol Oncol 105:166-71. 2007..Origin of metastases and time of detection in relation to surgery were recorded. Age at diagnosis, survival for ovarian metastasis compared to ovarian cancer and prognostic factors were evaluated...
Time, symptom burden, androgen deprivation, and self-assessed quality of life after radical prostatectomy or watchful waiting: the Randomized Scandinavian Prostate Cancer Group Study Number 4 (SPCG-4) clinical trialEva Johansson
Department of Urology, Uppsala University Hospital, Uppsala, Sweden
Eur Urol 55:422-30. 2009..Quality-of-life outcomes are important in the choice of treatment strategy for men with localized prostate cancer...
Season of diagnosis and prognosis in breast and prostate cancerLars Holmberg
Regional Oncologic Center and Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
Cancer Causes Control 20:663-70. 2009..Patients with breast or prostate cancer diagnosed during the summer season have been observed to have better survival. The extent to which this is due to biological and/or health care system related factors is unclear...
Distribution of coronary artery stenosis after radiation for breast cancerGreger Nilsson
Uppsala University, University Hospital, SE 751 85 Uppsala, Sweden
J Clin Oncol 30:380-6. 2012..To study distribution of coronary artery stenosis among patients with breast cancer (BC) and to assess correlation between radiotherapy (RT) and location of stenosis...
[Radical prostatectomy reduces the risk of death in prostatic cancer. The effect on total mortality can not be established yet as shown in a randomized controlled trial]Anna Bill-Axelson
Urologiska kliniken, Akademiska sjukhuset, Uppsala
Lakartidningen 100:1714-6. 2003
Increased risk of recurrence after hormone replacement therapy in breast cancer survivorsLars Holmberg
Department of Surgical Sciences, Uppsala University, Uppsala, Sweden
J Natl Cancer Inst 100:475-82. 2008..We present results after extended follow-up...
The metabolic syndrome and the risk of prostate cancer under competing risks of death from other causesBirgitta Grundmark
Regional Oncologic Centre, Uppsala University Hospital, Uppsala, Sweden
Cancer Epidemiol Biomarkers Prev 19:2088-96. 2010..Using the National Cholesterol Education Program Adult Treatment panel III (NCEP) and International Diabetes Federation (IDF) definitions of the MetS, we investigated such associations taking competing risks of death into consideration...
Experiences of randomization: interviews with patients and clinicians in the SPCG-IV trialAnna Bill-Axelson
Department of Urology, Uppsala University Hospital, Uppsala, Sweden
Scand J Urol Nephrol 42:358-63. 2008..This study investigated patients' and clinicians' experiences of randomization with the aim of facilitating trial participation in the future...
A randomized trial comparing radical prostatectomy with watchful waiting in early prostate cancerLars Holmberg
Regional Oncologic Center, University Hospital, Uppsala, Sweden
N Engl J Med 347:781-9. 2002..41 to 0.96). CONCLUSIONS: In this randomized trial, radical prostatectomy significantly reduced disease-specific mortality, but there was no significant difference between surgery and watchful waiting in terms of overall survival...
Regional differences in breast cancer survival despite common guidelinesSonja Eaker
Department of Surgery, Regional Oncologic Centre, University Hospital of Uppsala, SE 751 85 Uppsala, Sweden
Cancer Epidemiol Biomarkers Prev 14:2914-8. 2005..We therefore examined breast cancer survival in relation to differences in diagnostic activity, tumor characteristics, and treatment in seven Swedish counties within a single health care region...
CD99 is a novel prognostic stromal marker in non-small cell lung cancerKarolina Edlund
Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden
Int J Cancer 131:2264-73. 2012..The results support the concept that stromal properties have an important impact on tumour progression...
No increased prostate cancer incidence after negative transrectal ultrasound guided multiple biopsies in men with increased prostate specific antigen and/or abnormal digital rectal examinationAnna Bill-Axelson
Department of Urology, Uppsala University Hospital, Uppsala, Sweden
J Urol 170:1180-3. 2003..We investigated the incidence of prostate cancer after negative transrectal ultrasound (TRUS) guided multiple biopsies. Our secondary aim was to calculate the sensitivity of the extended protocol used...
Neoadjuvant cisplatin-methotrexate chemotherapy for invasive bladder cancer -- Nordic cystectomy trial 2Amir Sherif
Department of Urology, Akademiska University Hospital, Uppsala, Sweden
Scand J Urol Nephrol 36:419-25. 2002..CONCLUSIONS: The chemotherapy regimen was well tolerated. Despite substantial downstaging no statistically significant survival benefit with the neoadjuvant therapy could be seen after 5 years of follow-up...
Birth outcome in women with previously treated breast cancer--a population-based cohort study from SwedenKristina Dalberg
Department of Surgery and the Regional Oncologic Centre, Uppsala University Hospital, Uppsala, Sweden
PLoS Med 3:e336. 2006..The aim of this study was to assess the risk of adverse birth outcomes in women previously treated for invasive breast cancer compared with the general population of mothers...
Cyclin B is an immunohistochemical proliferation marker which can predict for breast cancer death in low-risk node negative breast cancerAnthoula Koliadi
Department of Oncology, Radiology and Clinical Immunology, Uppsala University, Uppsala, Sweden
Acta Oncol 49:816-20. 2010..Cyclin B is a proliferative marker easily assessed by immunohistochemistry. We wanted to examine cyclin B as a prognostic factor in low-risk breast cancer patients...
Increased incidence of stroke in women with breast cancerGreger Nilsson
Section of Oncology, Department of Oncology, Radiology and Clinical Immunology, University Hospital, SE 751 85 Uppsala, Sweden
Eur J Cancer 41:423-9. 2005..A statistically significant increase in the risk of stroke was seen among women with a history of breast cancer. Whether this risk is associated with the breast cancer disease per se or related to any treatment requires further study...
Survival endpoints in colorectal cancer and the effect of second primary other cancer on disease free survivalHelgi Birgisson
Department of Surgical Sciences, Colorectal Surgery, Uppsala University, Uppsala, Sweden
BMC Cancer 11:438. 2011..The aim of this study was to compare different survival endpoints in patients with primary colorectal cancer (CRC) and to understand the effect of second primary other cancer on disease-free survival (DFS) calculations...
Regional differences in treatment and outcome in non-small cell lung cancer: a population-based study (Sweden)Gunnar Myrdal
Department of Thoracic and Cardiovascular Surgery, Uppsala University Hospital, Uppsala, Sweden
Lung Cancer 63:16-22. 2009..Despite common guidelines there were marked differences in treatment activity between the counties. Treatment activity was associated with survival. Survival benefits may follow improvement in compliance to guidelines...
The role of the primary-care physician in oncology care. Primary healthcare and specialist cancer servicesLars Holmberg
Regional Oncologic Centre, Uppsala, Sweden
Lancet Oncol 6:121-2. 2005
Plasma vitamin D and mortality in older men: a community-based prospective cohort studyKarl Michaelsson
Department of Surgical Sciences and Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden
Am J Clin Nutr 92:841-8. 2010..Vitamin D status is known to be important for bone health but may also affect the development of several chronic diseases, including cancer and cardiovascular diseases, which are 2 major causes of death...
[Prostatic cancer in Sweden 1998-2003. Drastic change of the disease panorama]Eberhard Varenhorst
Lakartidningen 103:285-8. 2006
[Registries contribute to better breast cancer care]Leif Bergkvist
, Centrallasarettet,
Lakartidningen 101:2579-81. 2004
A 9-year follow-up study of participants and nonparticipants in sigmoidoscopy screening: importance of self-selectionJohannes Blom
Division of Surgery, Department for Clinical Science, Intervention and Technology, Karolinska Institutet at Karolinska University Hospital, K53, Huddinge, 141 86 Stockholm, Sweden
Cancer Epidemiol Biomarkers Prev 17:1163-8. 2008..Self-selection may compromise cost-effectiveness of screening programs. We hypothesized that nonparticipants have generally higher morbidity and mortality than participants...
Natural history of early, localized prostate cancerJan Erik Johansson
Department of Urology, Orebro University Hospital, Orebro, Sweden
JAMA 291:2713-9. 2004..However, little is known about disease progression and mortality beyond 10 to 15 years of watchful waiting...
Neoadjuvant cisplatinum based combination chemotherapy in patients with invasive bladder cancer: a combined analysis of two Nordic studiesAmir Sherif
Department of Urology, Akademiska University Hospital, SE 751 85 Uppsala, Sweden
Eur Urol 45:297-303. 2004..We analyzed overall survival in all patients and in prespecified subgroups defined by preoperative T-stage, gender and age...
[Quicker reporting to the Cancer Registry is required, according to a new regulation]Lotti Barlow
Epidemiologiskt centrum, Socialstyrelsen, Stockholm
Lakartidningen 100:3152-4. 2003
Clinical characteristics and primary treatment of prostate cancer in Sweden between 1996 and 2005Jan Adolfsson
Oncological Centre, Karolinska University Hospital, CLINTEC, Karolinska Institute, Stockholm, Sweden
Scand J Urol Nephrol 41:456-77. 2007..The incidence of prostate cancer is rising rapidly in Sweden and there is a need to better understand the pattern of diagnosis, tumor characteristics and treatment...
Long-term survival of patients with small intestinal carcinoid tumorsNiklas Zar
Department of Surgery, Ryhov County Hospital, , Sweden
World J Surg 28:1163-8. 2004..The divergence between cause-specific and relative survival implies the need for a more detailed analysis of the causes of death of these patients...
The National Prostate Cancer Register in Sweden 1998-2002: trends in incidence, treatment and survivalEberhard Varenhorst
Department of Urology, Faculty of Health Sciences, University Hospital Linkoping, Linkoping, Sweden
Scand J Urol Nephrol 39:117-23. 2005..To provide a descriptive review of the establishment of the National Prostate Cancer Register (NPCR) in Sweden, to present clinical characteristics at diagnosis and to calculate the relative survival of different risk groups after 5 years...
Lung cancer incidence in never smokersHeather A Wakelee
Division of Oncology, Department of Medicine, Stanford University School of Medicine, Stanford, USA
J Clin Oncol 25:472-8. 2007..However, data on this topic, particularly lung cancer incidence rates in never smokers, are limited...
Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohortsYudi Pawitan
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden
Breast Cancer Res 7:R953-64. 2005..Breast cancer expression profiling has so far mainly been used to identify women with a poor prognosis as candidates for adjuvant therapy but without demonstrated value for therapy prediction...
SweDCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screeningStefan O Emdin
Department of Surgery, Umea University Hospital, Umea, Sweden
Acta Oncol 45:536-43. 2006..Women undergoing sector resection for DCIS under conditions of population based screening mammography benefit from postoperative RT to the breast. Seven patients needed RT-treatment to prevent one recurrence...
Prostate-specific antigen levels as a predictor of lethal prostate cancerKatja Fall
Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Box 281, S 171 77 Stockholm, Sweden
J Natl Cancer Inst 99:526-32. 2007..Rates of long-term survival among patients with untreated localized prostate cancer are high. To avoid unnecessary treatment, tools are needed to identify the small proportion of patients who are destined to develop lethal prostate cancer...
The usefulness of a multidisciplinary educational programme after breast cancer surgery: a prospective and comparative studyIngaLill Koinberg
Department of Research 3D, Varberg Hospital, S 432 81 Varberg, Sweden
Eur J Oncol Nurs 10:273-82. 2006..A multidisciplinary educational programme may be an alternative to traditional follow-up by a physician after breast cancer surgery, but more research is needed about the financial benefits and effectiveness of such a programme...
Ductal carcinoma in situ of the breast with different histopathological grades and corresponding new breast tumour events: analysis of loss of heterozygosityJohanna Smeds
Department of Oncology Pathology, Radiumhemmet Cancer Centre Karolinska, Karolinska Institute and Hospital, S 171 76 Stockholm, Sweden
Acta Oncol 44:41-9. 2005..Also observed was a complete heterogeneity of LOH in the primary DCIS and their corresponding new events, suggesting that these events probably developed from genetically divergent clones...
The National Penile Cancer Register in Sweden 2000-2003Beata Persson
Departments of Urology, Orebro University Hospital, Orebro, Sweden
Scand J Urol Nephrol 41:278-82. 2007..The register elicits treatment disparities between regions, and aims to determine the impact of clinical practice guidelines introduced in Sweden...
Dietary calcium and vitamin D intake and risk of colorectal cancer: a prospective cohort study in womenPaul Terry
Department of Medical Epidemiology, Karolinska Institutet, Stockholm, Sweden
Nutr Cancer 43:39-46. 2002..Vitamin D intake was not clearly associated with risk. In sum, our data suggest that high calcium intake may lower colorectal cancer risk...
Absolute risk reductions for local recurrence after postoperative radiotherapy after sector resection for ductal carcinoma in situ of the breastLars Holmberg
Division of Cancer Studies, Thomas Guy House, 3rd Floor, King s College London, Guy s Campus, London SE1 9RT, United Kingdom
J Clin Oncol 26:1247-52. 2008..Evaluate the effects of radiotherapy after sector resection for ductal carcinoma in situ of the breast (DCIS) in patient groups as defined by age, size of the lesion, focality, completeness of excision and mode of detection...
The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish countiesStephen W Duffy
Department of Mathematics, Statistics and Epidemiology, Cancer Research UK, PO Box 123, Lincoln s Inn Fields, London WC2A 3PX, United Kingdom
Cancer 95:458-69. 2002..e., nonattenders) after the initiation of organized screening...
Breast cancer patients' satisfaction with a spontaneous system of check-up visits to a specialist nurseInga Lill Koinberg
Oncology Clinic, Varberg Hospital, Varberg, Sweden
Scand J Caring Sci 16:209-15. 2002..To describe breast cancer patients' satisfaction with a spontaneous system of check-up visits to a specialist nurse...
Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM-1VWD)Anne Goodeve
The Academic Unit of Haematology, University of Sheffield, United Kingdom
Blood 109:112-21. 2007..About one third of the type 1 VWD cases recruited could be reconsidered as type 2. The remaining group could be considered "true" type 1 VWD, although mutations were found in only 55%...
Red meat consumption and risk of cancers of the proximal colon, distal colon and rectum: the Swedish Mammography CohortSusanna C Larsson
Division of Nutritional Epidemiology, The National Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
Int J Cancer 113:829-34. 2005..04). These findings suggest that high consumption of red meat may substantially increase the risk of distal colon cancer. Future investigations on red meat and colorectal cancer risk should consider cancer subsites separately...
Overexpression of cyclin E protein is associated with specific mutation types in the p53 gene and poor survival in human breast cancerThomas Lindahl
Department of Oncology and Pathology, Radiumhemmet, Karolinska Hospital and Institute R8 03, S 171 76 Stockholm, Sweden
Carcinogenesis 25:375-80. 2004..4, 95% confidence interval 1.3-4.5). In summary, our findings demonstrate that overexpression of cyclin E is associated with an aggressive tumor phenotype and specific types of p53 mutations...
Toward understanding nonparticipation in sigmoidoscopy screening for colorectal cancerJohannes Blom
Division of Surgery, Department for Clinical Science, Intervention and Technology, Karolinska Institutet at Karolinska University Hospital, Huddinge, Stockholm, Sweden
Int J Cancer 122:1618-23. 2008..To increase compliance, invitations must appeal to men, unmarried or divorced people and people with low socioeconomic status...
Nine-gene molecular signature is not associated with prostate cancer death in a watchful waiting cohortLorelei A Mucci
Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115, USA
Cancer Epidemiol Biomarkers Prev 17:249-51. 2008..We quantified protein expression of the nine genes in tumors to classify progression risk. Accounting for clinical prognostic factors, the nine-gene model did not provide discrimination to predict lethal and indolent prostate cancer...
Risk of second primary malignancies and causes of death in patients with adenocarcinoma and carcinoid of the small intestineNiklas Zar
Department of Surgery, Ryhov County Hospital, Jonkoping, Sweden
Eur J Cancer 44:718-25. 2008..A detailed analysis of causes of death in a population-based cohort of small intestinal malignancies has not been presented before in the literature...
Residual adverse changes in arterial endothelial function and LDL oxidation after a mild systemic inflammation induced by influenza vaccinationPetru Liuba
Paediatric Cardiology, Lund University Hospital, Lund, Sweden
Ann Med 39:392-9. 2007....
Active surveillance for early-stage prostate cancer: review of the current literatureMarc A Dall'Era
Department of Urology, University of California at San Francisco Comprehensive Cancer Center, University of California at San Francisco, San Francisco, California 94143 1695, USA
Cancer 112:1650-9. 2008..The best candidates for active surveillance are being defined, as are predictors of active treatment. The psychosocial ramifications of surveillance for prostate cancer can be profound and future needs and unmet goals will be discussed...
Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM-1VWD)Sandra L Haberichter
Department of Pediatrics, Medical College of Wisconsin, Milwaukee, USA
Blood 111:4979-85. 2008..The systematic assay of both plasma VWF and the VWF propeptide in moderately severe type 1 VWD patients may identify patients with a reduced VWF survival phenotype...
Colorectal cancer survival in the Nordic countries and the United Kingdom: excess mortality risk analysis of 5 year relative period survival in the period 1999 to 2000Gerda Engholm
Department of Cancer Prevention and Documentation, Danish Cancer Society, Copenhagen, Denmark
Int J Cancer 121:1115-22. 2007..Use of more detailed age-intervals than conventionally applied in survival studies proved to be important in statistical modelling and is recommended for future studies...
Determinants of cancer patients' utilization of hospital care within two years after diagnosisBirgitta B K Johansson
Department of Oncology, Radiology and Clinical Immunology, the Section of Caring Sciences, Uppsala University, Sweden
Acta Oncol 43:536-44. 2004..The results suggest that thorough assessment can identify patients at diagnosis with an increased need for follow-up, e.g. intensified home care services...
Alcohol intake and colorectal cancer: a pooled analysis of 8 cohort studiesEunyoung Cho
Channing Laboratory, Brigham and Women s Hospital, Harvard Medical School, Harvard School of Public Health, and Harvard Center for Cancer Prevention, Boston, Massachusetts 02115, USA
Ann Intern Med 140:603-13. 2004..However, findings related to specific alcoholic beverages or different anatomic sites in the large bowel have been inconsistent...
Quality of life after radical prostatectomy or watchful waitingGunnar Steineck
Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden
N Engl J Med 347:790-6. 2002..We evaluated symptoms and self-assessments of quality of life in men with localized prostate cancer who participated in a randomized comparison between radical prostatectomy and watchful waiting...
